Dear All,
I am pleased to inform you that Save
the Children and GlaxoSmithKline (GSK) have launched a $1million Healthcare
Innovation Award fund as part of a wider global partnership to help save the
lives of a million of the world’s poorest children.
The fund aims to identify and reward
innovations in healthcare which have proven successful in reducing child deaths
in developing countries and which have the potential to be scaled-up and
replicated.
A total of $1 million USD has been
made available by GSK - $250,000 will be awarded to the best healthcare
innovation to further progress their work, with a total additional amount of
$750,000 available for runners-up awards.
Further details on the judging
process, eligibility and criteria can be found in the press release attached
and online at http://www.innocentive.com/ar/challenge/9933399 (live from 25th June).
Please consider your own
organisation’s eligibility to submit a nomination or other organisations you
may wish to nominate. You may also circulate the press release attached to any
organisations, networks or other contacts you feel would be interested in this
award fund.
By providing a platform for winning organisations to showcase their
innovations and share information, the award hopes to enable others with an
interest in improving healthcare to adapt and replicate interventions in order
to create more positive change for children in their own country and beyond.
Nominations for the award fund can be
submitted from the 27th June – 26th August and winners will be announced in mid-November.
Best wishes,
SharmisthaChakraborty
Project
Coordinator
SAVE THE
CHILDREN, INDIA
3rd Floor,
Vardhman Trade Centre, 9-10-11, Nehru Place, New Delhi-110 019
Landline: +91-11-4229-4900
Ext.231
Fax: +91-11-4229-4990
Cell No:
+91-8506066900
